What to Do When Anthem Denies Wegovy: Appeal Strategy

Introduction

Anthem owns 14 Blue Cross Blue Shield licensees across the US: California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, and Wisconsin. Anthem also administers many self-funded employer plans nationwide as the third-party administrator. Wegovy® denials at Anthem are processed through CarelonRx (formerly IngenioRx), Anthem’s wholly-owned PBM.

The denial reasons cluster around five issues: prior authorization criteria not met, step therapy required (often phentermine or Contrave first), BMI below threshold, weight-loss drug carve-out by the employer, and missing documentation of a structured weight management program. Each has a documented counter.

CMS data from 2023 puts the overturn rate at roughly 41 percent for commercial denials when patients file a level-1 internal appeal with new clinical documentation. The cardiovascular indication for Wegovy after SELECT (Lincoff et al. 2023, NEJM) and the FDA’s March 2024 approval has opened a separate appeal pathway on most Anthem plans.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Why Does Anthem Deny Wegovy?

Five denial codes account for roughly 85 percent of Anthem Wegovy rejections. The codes are PA-NOT-MET (PA criteria missing), NF (non-formulary), STEP-REQ (step therapy required), BMI-NOT-MET (BMI below threshold), and EMP-EXCL (employer carve-out for weight-loss drugs).

Quick Answer: Anthem processes Wegovy through CarelonRx; level-1 appeals go to CarelonRx first

Read your CarelonRx denial letter and find the reason code. The wording sits near a phrase reading “reason for adverse determination.” The appeal strategy depends on which code applies.

Anthem applies step therapy with phentermine or Contrave more aggressively than some other major insurers. About 60 percent of Anthem Wegovy denials in 2026 cite the step therapy requirement, either alone or in combination with other criteria failures.

What Is Anthem’s 2026 Prior Authorization for Wegovy?

Anthem’s 2026 commercial PA criteria for Wegovy require five elements: BMI of 30 or higher, or BMI 27 to 29.9 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, OSA, CVD), documentation of a structured weight management program for at least 6 months in the past 24 months, prescriber attestation that lifestyle changes alone have been inadequate, age 18 or older, and concurrent reduced-calorie diet and physical activity.

Most Anthem plans also require step therapy with phentermine, Contrave, or Qsymia before approving Wegovy. The step requirement can be waived with documented contraindications. Phentermine is contraindicated with CVD and uncontrolled hypertension. Contrave is contraindicated with seizure disorders, uncontrolled hypertension, and chronic opioid use.

The cardiovascular indication added in 2024 has separate, looser criteria: established CVD (prior MI, ischemic stroke, or symptomatic PAD) plus BMI of 27 or higher. The 6-month lifestyle program requirement is typically waived under the CV pathway, as is the step therapy requirement.

How Do I File a Level-1 Internal Appeal with Anthem?

You have 180 days from the denial date to file a level-1 internal appeal. The submission goes to CarelonRx Pharmacy Appeals at the address on the denial letter.

The appeal packet should include a signed appeal letter from you, a Letter of Medical Necessity signed by your prescriber, chart notes from the past 12 months, BMI and weight history, documentation of the 6-month weight management program, and prior medication trials with dates and outcomes. If you have a contraindication to phentermine or Contrave, document it with ICD-10 codes for the contraindicated conditions.

CarelonRx has 30 days to respond on a standard appeal and 72 hours on an expedited appeal. Expedited appeals require prescriber attestation that delay would seriously jeopardize health.

What Should the Letter of Medical Necessity Say?

The LMN is the single most important document. It should be on prescriber letterhead, signed and dated, and limited to two pages. CarelonRx reviewers spend about 6 minutes per appeal file on average.

Hit five points. First, current BMI and weight, plus BMI trend over 24 months. Second, every comorbidity that meets Anthem criteria with ICD-10 codes. Third, prior weight-loss interventions with dates and outcomes, including any prior GLP-1 trials and any step therapy attempts with phentermine, Contrave, or Qsymia. Fourth, clinical rationale citing STEP 1 (Wilding et al. 2021, NEJM) showing 14.9 percent weight loss at 68 weeks, and SELECT (Lincoff et al. 2023, NEJM) showing 20 percent MACE reduction. Fifth, a statement that lifestyle modifications alone have not produced sustained clinical response.

If you’re requesting step therapy override, document the contraindication or prior failure clearly. Anthem’s step therapy override criteria are explicit, and a clean documentation makes the override straightforward.

What Clinical Evidence Does Anthem Respect?

CarelonRx and Anthem’s P&T committee reference specific trials when updating coverage policy. Citing those trials by name puts your appeal in their internal vocabulary.

For Wegovy in 2026, the strongest references are STEP 1 (Wilding et al. 2021, NEJM), STEP-HFpEF (Kosiborod et al. 2023, NEJM) for heart failure with preserved ejection fraction, SELECT (Lincoff et al. 2023, NEJM) for the cardiovascular indication, and FLOW (Perkovic et al. 2024, NEJM) showing 24 percent reduction in kidney disease progression and CV death.

Pick the two trials most relevant to your clinical situation. A focused appeal is more credible than a literature review.

Key Takeaway: 2026 Anthem PA requires BMI of 30 or higher, or 27 with comorbidity, plus a 6-month documented weight management program

What If the First Appeal Is Denied?

You can file a level-2 internal appeal within 60 days of the level-1 denial, and pursue external review through your state insurance commissioner in parallel.

The level-2 internal appeal at Anthem goes to a different reviewer, usually a board-certified physician. The packet can include the same documents plus a peer-to-peer review request, where your prescriber speaks directly with Anthem’s medical director. Peer-to-peer reviews are typically granted and significantly improve overturn rates.

External review through your state insurance commissioner is independent of Anthem and decisions are binding. The deadline is usually 4 months from the final internal denial. The independent review organization assigns a board-certified physician in endocrinology or obesity medicine for Wegovy reviews. The review costs nothing. Approval rates at external review run around 50 percent for prescription drug denials.

How Does the SELECT Cardiovascular Indication Change the Appeal?

If you have a history of MI, ischemic stroke, or symptomatic peripheral arterial disease, your appeal should lead with the cardiovascular indication. The FDA approved Wegovy for CV risk reduction in March 2024, and most Anthem plans waive both the 6-month lifestyle program requirement and the step therapy requirement under that pathway.

The LMN should explicitly state “requested for cardiovascular risk reduction per FDA-approved indication based on SELECT trial.” Cite Lincoff et al. 2023 NEJM and note that SELECT enrolled 17,604 patients with established CVD and showed a hazard ratio of 0.80 for the primary MACE endpoint.

That framing reroutes the review to a different criteria set with higher approval rates.

What If My Anthem Plan Carves Out Weight-loss Drugs?

This is the hardest denial to overturn because the benefit design comes from the employer, not Anthem’s medical policy. You have three practical options.

First, ask HR whether the carve-out applies to all indications or only the obesity indication. The cardiovascular indication may be covered separately on some self-funded plans. Second, request a formulary exception based on medical necessity for documented CVD or type 2 diabetes with proven intolerance to alternatives. Third, consider cash-pay options. Compounded semaglutide through a licensed telehealth platform like TrimRx can be a fraction of the brand-name price, and a free assessment quiz determines eligibility in a few minutes.

Brand-name Wegovy through Novo Nordisk’s NovoCare savings card can drop the cost to as little as $0 for eligible commercially-insured patients, and the NovoCare Pharmacy direct cash program offers Wegovy at about $499 per month for cash-pay patients.

How Long Does the Full Appeal Process Take?

A standard level-1 internal appeal takes 30 days. A level-2 takes another 30 days. External review is usually 45 days but can be expedited to 72 hours with documented urgent medical need.

Full timeline if you exhaust every level: roughly 4 to 5 months from initial denial to a final external review decision. Expedited appeals can compress to 10 to 14 days end to end.

While appeals are pending, options include paying cash with a plan for retroactive reimbursement if the appeal succeeds, using the Wegovy savings card if eligible, or starting a personalized treatment plan with a compounded GLP-1 through a telehealth provider during the review window.

Bottom line: You have 180 days to file a level-1 internal appeal and 4 months for external review through your state commissioner

FAQ

Can I Appeal an Anthem Wegovy Denial Without My Doctor’s Help?

Possible but rare to succeed. The Letter of Medical Necessity from the prescriber carries clinical authority that a patient letter cannot match. Most prescribers will write one if you ask in writing and provide the denial letter.

Does Anthem Cover Wegovy for Medicare Patients?

Anthem Medicare Part D plans cover Wegovy only for the cardiovascular indication after the March 2024 CMS update. Coverage for weight loss alone is not available under Medicare. The PA requires established CVD with ICD-10 codes and BMI of 27 or higher.

Does Anthem Require STEP Therapy with Phentermine or Contrave?

Yes, on most plans. Anthem applies step therapy with phentermine, Contrave, or Qsymia before approving Wegovy. The requirement can be waived with documented contraindications. Phentermine is contraindicated with CVD and uncontrolled hypertension. Contrave is contraindicated with seizure disorders, uncontrolled hypertension, and chronic opioid use.

How Much Does Wegovy Cost with Anthem Coverage?

With PA approved on Tier 3, expect a copay of $40 to $100 per month for commercial plans. High-deductible plans charge the full negotiated rate (around $900 to $1,000 per month) until the deductible is met. Without coverage, brand-name Wegovy lists at about $1,349 per month, with NovoCare savings and direct cash options.

Can I Switch to Compounded Semaglutide If the Appeal Fails?

Yes. Compounded semaglutide from a licensed 503A pharmacy is the same active ingredient as Wegovy, prescribed through telehealth platforms like TrimRx after a clinical assessment. Costs run roughly $199 to $399 per month depending on dose. Compounding is legal when prescribed for an individual patient based on clinical need.

What Documents Does CarelonRx Want in a Wegovy Appeal?

A signed appeal letter from you, a Letter of Medical Necessity from your prescriber, chart notes from the past 12 months, BMI and weight history, documentation of the 6-month weight management program, prior medication trials with dates, and documentation of any contraindications to step therapy drugs.

Can I Get an Expedited Appeal If I Have Type 2 Diabetes?

Yes, in most cases. Expedited appeals are granted when delay would seriously jeopardize health. Uncontrolled type 2 diabetes with elevated A1C, recent hypoglycemic events, or evidence of microvascular complications all support an expedited request. The prescriber must attest to urgency in writing.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.

Related Articles

• What to Do When Aetna Denies Wegovy: Appeal Strategy
• What to Do When Medicare Denies Wegovy: Appeal Strategy
• What to Do When Tricare Denies Zepbound: Step-by-Step Appeal
• What to Do When BCBS Blue Cross Blue Shield Denies Wegovy: Appeal Strategy